Keywords: merck, co, cozaar, share, ace, market, angiotensin

Merck & Co's Cozaar: share of US ACE market

Article | 21 August 1995

Print This

- Merck & Co's angiotensin II antagonist Cozaar (losartan) has claimed a 2.5% share of the ACE inhibitor market in the USA, according ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in